Pharmacology Watch – April 1, 2014

April 1, 2014

• Warfarin and chronic kidney disease

  Evidence-based updates in clinical pharmacology .

  In this issue: Warfarin and chronic kidney disease; pregabalin for restless legs syndrome; bevacizumab for glioblastoma and advanced cervical cancer; and FDA actions.

  Read more

• Pregabalin for restless legs syndrome

  Read more

• Bevacizumab for glioblastoma and advanced cervical cancer

  Read more

• FDA Actions

  Read more